# Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study

> **NCT02049528** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 18 (actual)

## Conditions studied

- Clinical Pharmacology, Healthy Male Volunteer Study

## Interventions

- **DRUG:** CC-122
- **DRUG:** CC-122
- **DRUG:** CC-122

## Key facts

- **NCT ID:** NCT02049528
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-16
- **Primary completion:** 2014-02-02
- **Final completion:** 2014-02-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049528, "Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02049528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*